Who Owns Amplify Weight Loss Drug & Treatment ETF (THNR)?Hedge Fund & Institutional Holders

$24.36-0.05 (-0.20%)Financial ServicesNYSE_ARCA

Institutional Holders

2

as of Q4 2025

Total Institutional Value

$3.9B

% of Float Held

QoQ Change in Holders

+2 / -2

Price History

$18.85$21.06$23.27$25.49$27.70Sep 24Jun 25Mar 26

THNR — Biggest New Institutional Buyers This Quarter

FundActionShares AddedValue Added
Cravens & Co Advisors, LLCNew Position+15K+$390.0M
Godfrey Financial Associates, Inc.New Position+201+$5K

THNR — Institutions Reducing or Closing Positions

FundActionShares SoldValue Sold
JANE STREET GROUP, LLCClosed Position-24K-$554.8M
UBS Group AGClosed Position-2K-$51.1M

Top Institutional Holders(Q4 2025)

#FundSharesValue% of PortfolioType
1Cravens & Co Advisors, LLC15,023$390.0M0.26%Share
2Godfrey Financial Associates, Inc.201$5K0.00%Share

THNR Institutional Ownership History

QuarterHoldersTotal ValueChange
Q4 20252$390.0M+0
Q3 20252$606.0M-1
Q2 20253$187.1M-1
Q1 20254$1.4B-1
Q4 20245$1.3B+0
Q3 20245$987.8B+2
Q2 20243$726.7B

Similar Stocks by Institutional Ownership

As of Q4 2025, 2 institutional investors hold THNR (Amplify Weight Loss Drug & Treatment ETF). The largest holder is Cravens & Co Advisors, LLC with $390.0M in shares. This quarter, 2 institutions opened new positions and 2 closed their positions.

Frequently Asked Questions

How many hedge funds own THNR?

As of Q4 2025, 2 institutional investors report holding THNR (Amplify Weight Loss Drug & Treatment ETF) in their 13F filings.

Who is the largest institutional holder of THNR?

The largest institutional holder of THNR is Cravens & Co Advisors, LLC with $390.0M in shares.

Is institutional ownership of THNR increasing or decreasing?

This quarter, 2 institutions opened new positions in THNR and 2 closed their positions.